<VariationArchive VariationID="280043" VariationName="NM_172107.4(KCNQ2):c.1229del (p.Pro410fs)" VariationType="Deletion" Accession="VCV000280043" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2016-12-06" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="264761" VariationID="280043">
      <GeneList>
        <Gene Symbol="KCNQ2" FullName="potassium voltage-gated channel subfamily Q member 2" GeneID="3785" HGNC_ID="HGNC:6296" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63400208" stop="63472655" display_start="63400208" display_stop="63472655" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NT_187625.1" start="183" stop="33239" display_start="183" display_stop="33239" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62037541" stop="62103992" display_start="62037541" display_stop="62103992" Strand="-" />
          </Location>
          <OMIM>602235</OMIM>
          <Haploinsufficiency last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_172107.4(KCNQ2):c.1229del (p.Pro410fs)</Name>
      <CanonicalSPDI>NC_000020.11:63424194:GGGGGG:GGGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63424195" stop="63424195" display_start="63424195" display_stop="63424195" variantLength="1" positionVCF="63424194" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62055548" stop="62055548" display_start="62055548" display_stop="62055548" variantLength="1" positionVCF="62055547" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P410fs</ProteinChange>
      <ProteinChange>P400fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.62055553del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.62055553del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.63424200del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.63424200del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009004.2" sequenceAccession="NG_009004" sequenceVersion="2" change="g.53446del">
            <Expression>NG_009004.2:g.53446del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004518.6" sequenceAccession="NM_004518" sequenceVersion="6" change="c.1199del">
            <Expression>NM_004518.6:c.1199del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004509.2" sequenceAccession="NP_004509" sequenceVersion="2" change="p.Pro400fs">
            <Expression>NP_004509.2:p.Pro400fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172106.3" sequenceAccession="NM_172106" sequenceVersion="3" change="c.1229del">
            <Expression>NM_172106.3:c.1229del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742104.1" sequenceAccession="NP_742104" sequenceVersion="1" change="p.Pro410fs">
            <Expression>NP_742104.1:p.Pro410fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172107.4" sequenceAccession="NM_172107" sequenceVersion="4" change="c.1229del" MANESelect="true">
            <Expression>NM_172107.4:c.1229del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742105.1" sequenceAccession="NP_742105" sequenceVersion="1" change="p.Pro410fs">
            <Expression>NP_742105.1:p.Pro410fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172108.5" sequenceAccession="NM_172108" sequenceVersion="5" change="c.1229del">
            <Expression>NM_172108.5:c.1229del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742106.1" sequenceAccession="NP_742106" sequenceVersion="1" change="p.Pro410fs">
            <Expression>NP_742106.1:p.Pro410fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172107.2" sequenceAccession="NM_172107" sequenceVersion="2" change="c.1229del">
            <Expression>NM_172107.2:c.1229del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10603368" DB="ClinGen" />
        <XRef Type="rs" ID="886041339" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.1229del (p.Pro410fs) AND not provided" Accession="RCV000408251" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-10-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.1229del (p.Pro410fs) AND Seizures, benign familial neonatal, 1" Accession="RCV001004684" Version="2">
        <ClassifiedConditionList TraitSetID="2010">
          <ClassifiedCondition DB="MedGen" ID="C3149074">Seizures, benign familial neonatal, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.1229del (p.Pro410fs) AND Early infantile epileptic encephalopathy with suppression bursts" Accession="RCV003588607" Version="1">
        <ClassifiedConditionList TraitSetID="21987">
          <ClassifiedCondition DB="MedGen" ID="C0393706">Early infantile epileptic encephalopathy with suppression bursts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-10" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-12-06" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14534157</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19559753</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23692823</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27779742</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21987" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32998" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ohtahara syndrome</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Developmental and epileptic encephalopathy</ElementValue>
                <XRef ID="MONDO:0100062" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Early infantile epileptic encephalopathy with suppression bursts</ElementValue>
                <XRef ID="230429005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EIEE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9255" />
                <XRef ID="9255" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C0393706" DB="MedGen" />
              <XRef ID="MONDO:0100062" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS308350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2010" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5025" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">KCNQ2-Related Benign Familial Neonatal Epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Benign Neonatal Epilepsy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial neonatal, 1</ElementValue>
                <XRef ID="MONDO:0007365" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFNS1</ElementValue>
                <XRef Type="MIM" ID="121200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes ranging from self-limited familial neonatal epilepsy (SLFNE) at the mild end to neonatal-onset developmental and epileptic encephalopathy (NEO-DEE) at the severe end. Additional, less common phenotypes consisting of neonatal encephalopathy with non-epileptic myoclonus, infantile or childhood-onset developmental and epileptic encephalopathy (DEE), and isolated intellectual disability (ID) without epilepsy have also been described. KCNQ2-SLFNE is characterized by seizures that start in otherwise healthy infants between two and eight days after term birth and spontaneously disappear between the first and the sixth to 12th month of life. There is always a seizure-free interval between birth and the onset of seizures. Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis; video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution. About 30% of individuals with KCNQ2-SLFNE develop epileptic seizures later in life. KCNQ2-NEO-DEE is characterized by multiple daily seizures beginning in the first week of life that are mostly tonic, with associated focal motor and autonomic features. Seizures generally cease between ages nine months and four years. At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia hyperdensities and later MRIs may show white matter or general volume loss. Moderate-to-profound developmental impairment is present.</Attribute>
                <XRef ID="NBK32534" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20437616</ID>
                <ID Source="BookShelf">NBK32534</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="1949" DB="Orphanet" />
              <XRef ID="C3149074" DB="MedGen" />
              <XRef ID="MONDO:0007365" DB="MONDO" />
              <XRef Type="MIM" ID="121200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="643153" SubmissionDate="2019-01-29" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDX:665609|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000329803" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="6" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-10-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1229delC pathogenic variant in the KCNQ2 gene has been reported previously in association with neonatal convulsions (Volkers et al., 2009). Due to use of alternative nomenclature, this variant was reported as P410fs12X in this study (Volkers et al., 2009). Functional studies show that this variant impairs the function as well as trafficking of the KCNQ2 protein (Volkers et al., 2009). The deletion causes a frameshift starting with codon Proline 410, changes this amino acid to an Arginine residue and creates a premature Stop codon at position 30 of the new reading frame, denoted p.Pro410ArgfsX30. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Additionally, it was not observed in approximately 6,300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_172107.2:c.1229delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2293790" SubmissionDate="2019-05-24" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey="16A3699|OMIM:121200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164141" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Génétique des Maladies du Développement, Hospices Civils de Lyon" OrgID="506599" OrganizationCategory="laboratory" OrgAbbreviation="HCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19559753</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Epilepsy NGS panel</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_172107.2:c.1229del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="121200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>PAGEM-oct-2018</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983892" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4960956|MedGen:C0393706" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004297358" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14534157</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23692823</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27779742</ID>
          </Citation>
          <Comment>The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 280043). This variant has not been reported in the literature in individuals affected with KCNQ2-related conditions. This sequence change creates a premature translational stop signal (p.Pro410Argfs*30) in the KCNQ2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ2 are known to be pathogenic (PMID: 14534157, 23692823, 27779742).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.62055548del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393706" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2293790" TraitType="Disease" MappingType="XRef" MappingValue="121200" MappingRef="OMIM">
        <MedGen CUI="C3149074" Name="Seizures, benign familial neonatal, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7983892" TraitType="Disease" MappingType="XRef" MappingValue="C0393706" MappingRef="MedGen">
        <MedGen CUI="C0393706" Name="Early infantile epileptic encephalopathy with suppression bursts" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="643153" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

